130 related articles for article (PubMed ID: 33799173)
21. Apoptosis induced by 5-(N,N-hexamethylene)-amiloride in regenerating liver after partial hepatectomy.
Suzuki T; Tsukamoto I
Eur J Pharmacol; 2004 Oct; 503(1-3):1-7. PubMed ID: 15496288
[TBL] [Abstract][Full Text] [Related]
22. Comparative effects of Na+/H+ exchange inhibitors against cardiac injury produced by ischemia/reperfusion, hypoxia/reoxygenation, and the calcium paradox.
Karmazyn M; Ray M; Haist JV
J Cardiovasc Pharmacol; 1993 Jan; 21(1):172-8. PubMed ID: 7678674
[TBL] [Abstract][Full Text] [Related]
23. Amiloride analogs inhibit L-type calcium channels and display calcium entry blocker activity.
Garcia ML; King VF; Shevell JL; Slaughter RS; Suarez-Kurtz G; Winquist RJ; Kaczorowski GJ
J Biol Chem; 1990 Mar; 265(7):3763-71. PubMed ID: 2154487
[TBL] [Abstract][Full Text] [Related]
24. Computer-aided drug design and virtual screening of targeted combinatorial libraries of mixed-ligand transition metal complexes of 2-butanone thiosemicarbazone.
Khan T; Ahmad R; Azad I; Raza S; Joshi S; Khan AR
Comput Biol Chem; 2018 Aug; 75():178-195. PubMed ID: 29883916
[TBL] [Abstract][Full Text] [Related]
25. Urokinase-type Plasminogen Activator Is a Therapeutic Target for Overcoming Sorafenib Resistance in Hepatoma Cells.
Osawa M; Matsuda Y; Kinoshita Y; Wakai T
Anticancer Res; 2021 Feb; 41(2):645-660. PubMed ID: 33517269
[TBL] [Abstract][Full Text] [Related]
26. Fluorescence properties of the Na⁺/H⁺exchanger inhibitor HMA (5-(N,N-hexamethylene)amiloride) are modulated by intracellular pH.
Giansanti V; Santamaria G; Torriglia A; Aredia F; Scovassi AI; Bottiroli G; Croce AC
Eur J Histochem; 2012 Jan; 56(1):e3. PubMed ID: 22472891
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of urokinase by 4-substituted benzo[b]thiophene-2-carboxamidines: an important new class of selective synthetic urokinase inhibitor.
Towle MJ; Lee A; Maduakor EC; Schwartz CE; Bridges AJ; Littlefield BA
Cancer Res; 1993 Jun; 53(11):2553-9. PubMed ID: 8495419
[TBL] [Abstract][Full Text] [Related]
28. Urokinase-type plasminogen activator (uPA) is not essential for epithelial sodium channel (ENaC)-mediated sodium retention in experimental nephrotic syndrome.
Bohnert BN; Daiminger S; Wörn M; Sure F; Staudner T; Ilyaskin AV; Batbouta F; Janessa A; Schneider JC; Essigke D; Kanse S; Haerteis S; Korbmacher C; Artunc F
Acta Physiol (Oxf); 2019 Dec; 227(4):e13286. PubMed ID: 31006168
[TBL] [Abstract][Full Text] [Related]
29. In vitro suppression of Pseudomonas cepacia after limited exposure to subinhibitory concentrations of amiloride and 5-(N,N-hexamethylene) amiloride.
Cohn RC; Rudzienski L
Pediatr Pulmonol; 1994 Jun; 17(6):366-9. PubMed ID: 7522319
[TBL] [Abstract][Full Text] [Related]
30. Amiloride derivatives and a nonpeptidic antagonist bind at two distinct allosteric sites in the human gonadotropin-releasing hormone receptor.
Heitman LH; Ye K; Oosterom J; Ijzerman AP
Mol Pharmacol; 2008 Jun; 73(6):1808-15. PubMed ID: 18344315
[TBL] [Abstract][Full Text] [Related]
31. Binding site of amiloride to urokinase plasminogen activator depends on species.
Jankun J; Skrzypczak-Jankun E
Int J Mol Med; 2001 Oct; 8(4):365-71. PubMed ID: 11562773
[TBL] [Abstract][Full Text] [Related]
32. Mis-trafficking of endosomal urokinase proteins triggers drug-induced glioma nonapoptotic cell death.
Pasupuleti N; Grodzki AC; Gorin F
Mol Pharmacol; 2015 Apr; 87(4):683-96. PubMed ID: 25634671
[TBL] [Abstract][Full Text] [Related]
33. The Antifungal Activity of HMA, an Amiloride Analog and Inhibitor of Na
Vu K; Blumwald E; Gelli A
Front Microbiol; 2021; 12():673035. PubMed ID: 34025629
[TBL] [Abstract][Full Text] [Related]
34. The ATP4- receptor-operated ion channel of human lymphocytes: inhibition of ion fluxes by amiloride analogs and by extracellular sodium ions.
Wiley JS; Chen R; Wiley MJ; Jamieson GP
Arch Biochem Biophys; 1992 Feb; 292(2):411-8. PubMed ID: 1370600
[TBL] [Abstract][Full Text] [Related]
35. Killing Glioma 'Stem-like' Cells via Drug-Induced Relocation of Endosomal Urokinase Proteins.
Gorin FA; Pasupuleti N; Mahajan D; Dugar S
Anticancer Agents Med Chem; 2017; 17(1):40-47. PubMed ID: 27357540
[TBL] [Abstract][Full Text] [Related]
36. Effects of 5-(N,N-hexamethylene)amiloride on action potentials, intracellular Na, and pH of guinea pig ventricular muscle in vitro.
Lai ZF; Hotokebuchi N; Cragoe EJ; Nishi K
J Cardiovasc Pharmacol; 1994 Feb; 23(2):259-67. PubMed ID: 7511756
[TBL] [Abstract][Full Text] [Related]
37. Receptor binding profiles of amiloride analogues provide no evidence for a link between receptors and the Na+/H+ exchanger, but indicate a common structure on receptor proteins.
Garritsen A; Ijzerman AP; Tulp MT; Cragoe EJ; Soudijn W
J Recept Res; 1991; 11(6):891-907. PubMed ID: 1661335
[TBL] [Abstract][Full Text] [Related]
38. Receptor-bound uPA is reversibly protected from inhibition by low molecular weight inhibitors.
Dyer KD; Linz-Mcgillem LA; Alliegro MA; Alliegro MC
Cell Biol Int; 2002; 26(4):327-35. PubMed ID: 11991662
[TBL] [Abstract][Full Text] [Related]
39. Amiloride inhibition of angiogenesis in vitro.
Alliegro MC; Alliegro MA; Cragoe EJ; Glaser BM
J Exp Zool; 1993 Nov; 267(3):245-52. PubMed ID: 7693860
[TBL] [Abstract][Full Text] [Related]
40. Mechanisms of Action of Novel Influenza A/M2 Viroporin Inhibitors Derived from Hexamethylene Amiloride.
Jalily PH; Eldstrom J; Miller SC; Kwan DC; Tai SS; Chou D; Niikura M; Tietjen I; Fedida D
Mol Pharmacol; 2016 Aug; 90(2):80-95. PubMed ID: 27193582
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
